We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IMAGING FIRM WARNED FOR GMP, MANAGEMENT CONTROL FAILURES
IMAGING FIRM WARNED FOR GMP, MANAGEMENT CONTROL FAILURES
March 12, 2004
The FDA has issued a warning letter to Dublin, Calif.-based Obsidian Medical Technology for allegedly violating numerous good manufacturing practice requirements of the quality system regulation (QSR).